Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 21

1.

Optimizing Infant HIV Diagnosis in Resource-Limited Settings: Modeling the Impact of HIV DNA PCR Testing at Birth.

Chiu A, Modi S, Rivadeneira ED, Koumans EH.

J Acquir Immune Defic Syndr. 2016 Dec 1;73(4):454-462.

2.

Specimen Referral Network to Rapidly Scale-Up CD4 Testing: The Hub and Spoke Model for Haiti.

Louis FJ, Osborne AJ, Elias VJ, Buteau J, Boncy J, Elong A, Dismer A, Sasi V, Domercant JW, Lauture D, Balajee SA, Marston BJ.

J AIDS Clin Res. 2015;6(8). pii: 1000488.

3.

Plasma viraemia in HIV-positive pregnant women entering antenatal care in South Africa.

Myer L, Phillips TK, Hsiao NY, Zerbe A, Petro G, Bekker LG, McIntyre JA, Abrams EJ.

J Int AIDS Soc. 2015 Jul 6;18:20045. doi: 10.7448/IAS.18.1.20045.

4.

Risk factors for loss to follow-up prior to ART initiation among patients enrolling in HIV care with CD4+ cell count ≥200 cells/μL in the multi-country MTCT-Plus Initiative.

Gwynn RC, Fawzy A, Viho I, Wu Y, Abrams EJ, Nash D.

BMC Health Serv Res. 2015 Jun 25;15:247. doi: 10.1186/s12913-015-0898-9.

5.

Point-of-care CD4 testing to inform selection of antiretroviral medications in south african antenatal clinics: a cost-effectiveness analysis.

Ciaranello AL, Myer L, Kelly K, Christensen S, Daskilewicz K, Doherty K, Bekker LG, Hou T, Wood R, Francke JA, Wools-Kaloustian K, Freedberg KA, Walensky RP.

PLoS One. 2015 Mar 10;10(3):e0117751. doi: 10.1371/journal.pone.0117751.

6.

Individualizing the WHO HIV and infant feeding guidelines: optimal breastfeeding duration to maximize infant HIV-free survival.

Ciaranello AL, Leroy V, Rusibamayila A, Freedberg KA, Shapiro R, Engelsmann B, Lockman S, Kelly KA, Dabis F, Walensky RP.

AIDS. 2014 Jul;28 Suppl 3:S287-99. doi: 10.1097/QAD.0000000000000337.

7.

Diagnostic accuracy of the WHO clinical staging system for defining eligibility for ART in sub-Saharan Africa: a systematic review and meta-analysis.

Munthali C, Taegtmeyer M, Garner PG, Lalloo DG, Squire SB, Corbett EL, Ford N, MacPherson P.

J Int AIDS Soc. 2014 Jun 12;17:18932. doi: 10.7448/IAS.17.1.18932. Review.

8.

The incremental cost of switching from Option B to Option B+ for the prevention of mother-to-child transmission of HIV.

O'Brien L, Shaffer N, Sangrujee N, Abimbola TO.

Bull World Health Organ. 2014 Mar 1;92(3):162-70. doi: 10.2471/BLT.13.122523.

9.

Health outcomes and cost impact of the new WHO 2013 guidelines on prevention of mother-to-child transmission of HIV in Zambia.

Ishikawa N, Shimbo T, Miyano S, Sikazwe I, Mwango A, Ghidinelli MN, Syakantu G.

PLoS One. 2014 Mar 6;9(3):e90991. doi: 10.1371/journal.pone.0090991.

10.

Tracking the progress of HIV: the impact of point-of-care tests on antiretroviral therapy.

Reid SD, Fidler SJ, Cooke GS.

Clin Epidemiol. 2013 Sep 26;5:387-96. doi: 10.2147/CLEP.S37069. Review.

11.

A novel community health worker tool outperforms WHO clinical staging for assessment of antiretroviral therapy eligibility in a resource-limited setting.

Macpherson P, Lalloo DG, Thindwa D, Webb EL, Squire SB, Chipungu GA, Desmond N, Makombe SD, Taegtmeyer M, Choko AT, Corbett EL.

J Acquir Immune Defic Syndr. 2014 Feb 1;65(2):e74-8. doi: 10.1097/QAI.0b013e3182a20e74.

12.

Impact of expanded access to combination antiretroviral therapy in pregnancy: results from a cohort study in Ukraine.

Bailey H, Townsend CL, Semenenko I, Malyuta R, Cortina-Borja M, Thorne C; Ukraine European Collaborative Study Group in EuroCoord..

Bull World Health Organ. 2013 Jul 1;91(7):491-500. doi: 10.2471/BLT.12.114405.

13.

Prevention of mother-to-child transmission of HIV: cost-effectiveness of antiretroviral regimens and feeding options in Rwanda.

Binagwaho A, Pegurri E, Drobac PC, Mugwaneza P, Stulac SN, Wagner CM, Karema C, Tsague L.

PLoS One. 2013;8(2):e54180. doi: 10.1371/journal.pone.0054180.

14.

Integrating antiretroviral therapy into antenatal care and maternal and child health settings: a systematic review and meta-analysis.

Suthar AB, Hoos D, Beqiri A, Lorenz-Dehne K, McClure C, Duncombe C.

Bull World Health Organ. 2013 Jan 1;91(1):46-56. doi: 10.2471/BLT.12.107003. Review.

15.

Cost-effectiveness of World Health Organization 2010 guidelines for prevention of mother-to-child HIV transmission in Zimbabwe.

Ciaranello AL, Perez F, Engelsmann B, Walensky RP, Mushavi A, Rusibamayila A, Keatinge J, Park JE, Maruva M, Cerda R, Wood R, Dabis F, Freedberg KA.

Clin Infect Dis. 2013 Feb;56(3):430-46. doi: 10.1093/cid/cis858.

16.

Quantifying and addressing losses along the continuum of care for people living with HIV infection in sub-Saharan Africa: a systematic review.

Kranzer K, Govindasamy D, Ford N, Johnston V, Lawn SD.

J Int AIDS Soc. 2012 Nov 19;15(2):17383. doi: 10.7448/IAS.15.2.17383. Review.

17.

Systemic delays in the initiation of antiretroviral therapy during pregnancy do not improve outcomes of HIV-positive mothers: a cohort study.

Myer L, Zulliger R, Bekker LG, Abrams E.

BMC Pregnancy Childbirth. 2012 Sep 11;12:94. doi: 10.1186/1471-2393-12-94.

18.

What will it take to eliminate pediatric HIV? Reaching WHO target rates of mother-to-child HIV transmission in Zimbabwe: a model-based analysis.

Ciaranello AL, Perez F, Keatinge J, Park JE, Engelsmann B, Maruva M, Walensky RP, Dabis F, Chu J, Rusibamayila A, Mushavi A, Freedberg KA.

PLoS Med. 2012 Jan;9(1):e1001156. doi: 10.1371/journal.pmed.1001156.

19.

Pregnant women's access to PMTCT and ART services in South Africa and implications for universal antiretroviral treatment.

Hussain A, Moodley D, Naidoo S, Esterhuizen TM.

PLoS One. 2011;6(12):e27907. doi: 10.1371/journal.pone.0027907.

20.

WHO 2010 guidelines for prevention of mother-to-child HIV transmission in Zimbabwe: modeling clinical outcomes in infants and mothers.

Ciaranello AL, Perez F, Maruva M, Chu J, Engelsmann B, Keatinge J, Walensky RP, Mushavi A, Mugwagwa R, Dabis F, Freedberg KA; CEPAC-International Investigators..

PLoS One. 2011;6(6):e20224. doi: 10.1371/journal.pone.0020224.

Supplemental Content

Support Center